Antibiotic therapy for bacterial pneumonia.
Hideo KatoPublished in: Journal of pharmaceutical health care and sciences (2024)
Pneumonia is a common infection in patients of all ages. Determining its etiology and selecting antibiotic therapy are challenging for physicians in both private practice and hospitals. Moreover, the coronavirus disease pandemic revealed the importance of prevention and treatment of secondary bacterial pneumonia in patients hospitalized with viral respiratory infections. This review focuses on the types of bacteria that cause pneumonia and provides new insights into antibiotic therapy for bacterial pneumonia. Moreover, it also reviews the current state of knowledge regarding secondary bacterial pneumonia.
Keyphrases
- coronavirus disease
- end stage renal disease
- healthcare
- chronic kidney disease
- ejection fraction
- newly diagnosed
- sars cov
- primary care
- prognostic factors
- respiratory failure
- community acquired pneumonia
- peritoneal dialysis
- randomized controlled trial
- patient reported outcomes
- stem cells
- systematic review
- intensive care unit
- combination therapy
- health insurance
- respiratory tract
- extracorporeal membrane oxygenation
- patient reported
- smoking cessation